Braskem S.A. is facing a significant challenge as FFI Fund Ltd., FYI Ltd., and Olifant Fund Ltd. have filed an involuntary Chapter 11 petition against its subsidiary, Braskem America Finance Company. This petition was filed in the United States Bankruptcy Court for the Southern District of New York on October 21, 2026, and highlights potential financial distress for the company.
The petitioning creditors hold a beneficial interest in the 7.125% Notes due 2041 issued by Braskem America Finance and guaranteed by Braskem S.A. The principal amount of these notes is approximately $272 million, which represents about 47% of the aggregate outstanding principal amount of the 2041 Notes.
Background
Braskem S.A. operates in the industrial organic chemicals sector, specifically focusing on the production of petrochemicals. The company trades under the ticker BAK on the New York Stock Exchange and has a significant presence in Brazil, where it is based in Camacari, Bahia. The company is categorized as a large accelerated filer and has been active in the market with multiple recent filings, including several 6-K forms.
What the Filing Says
According to the filing, the Chapter 11 petition relates solely to Braskem America Finance and its indebtedness, which consists exclusively of the 2041 Notes in the principal amount of approximately $589 million. Notably, Braskem S.A. and its other subsidiaries are not listed as debtors in this petition.
Impact
This development may affect Braskem's ability to manage its debts and could have broader implications for its operations and financial health. The ongoing extrajudicial reorganization in Brazil and the Chapter 15 cases in the United States add complexity to the situation, potentially impacting stakeholders, including investors and creditors.
What's Next
The filing does not specify what happens next for Braskem S.A. or its subsidiary in light of this Chapter 11 petition.